{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:27:53Z","timestamp":1773444473255,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.mayocpiqo.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T23:00:08Z","timestamp":1640127608000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment of Uveal Melanoma With Radioactive Iodine 125 Implant Compared With Proton Beam Radiotherapy"],"prefix":"10.1016","volume":"6","author":[{"given":"James P.","family":"Bolling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roi","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rutenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mamalui-Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Buskirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander P.","family":"Hochwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roelf","family":"Slopsema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mayocpiqo.2021.10.002_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.10.002_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the","volume":"103","author":"McLaughlin","year":"2005","journal-title":"U.S. Cancer"},{"key":"10.1016\/j.mayocpiqo.2021.10.002_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.10.002_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/CMR.0000000000000575","article-title":"Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis","volume":"29","author":"Rantala","year":"2019","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.10.002_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2021.10.002_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2021.10.002_bib7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.10.002_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/bjo.2007.133249","article-title":"Primary transpupillary thermotherapy of \"small\" choroidal melanoma: is it safe?","volume":"92","author":"Singh","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2021.10.002_bib9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0025-6196(12)60072-X","article-title":"Current management of posterior uveal melanoma","volume":"68","author":"Shields","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2021.10.002_bib10","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1111\/aos.13306","article-title":"Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients \u2013 the Tuebingen experience","volume":"95","author":"S\u00fcsskind","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.10.002_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/0974-9233.65494","article-title":"Exoresection and endoresection for uveal melanoma","volume":"17","author":"G\u00fcnd\u00fcz","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.10.002_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/COC.0000000000000775","article-title":"Systematic review and meta-analysis on the use of photon-based stereotactic radiosurgery versus fractionated stereotactic radiotherapy for the treatment of uveal melanoma","volume":"44","author":"Kosydar","year":"2021","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.10.002_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.brachy.2017.11.004","article-title":"Ruthenium brachytherapy for uveal melanomas: factors affecting the development of radiation complications","volume":"17","author":"Pagliara","year":"2018","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.10.002_bib14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/1120672118776146","article-title":"Regression patterns of choroidal melanoma: after palladium-103 (103Pd) plaque brachytherapy","volume":"28","author":"Maheshwari","year":"2018","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.10.002_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13014-020-01621-4","article-title":"106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma","volume":"15","author":"Jiang","year":"2020","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.10.002_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings; COMS Report No. 18","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.10.002_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5114\/jcb.2020.98108","article-title":"Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database","volume":"12","author":"Messer","year":"2020","journal-title":"J\u00a0Contemp Brachytherapy"},{"key":"10.1016\/j.mayocpiqo.2021.10.002_bib18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2147\/OPTH.S129645","article-title":"Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions","volume":"12","author":"Brewington","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.10.002_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bjophthalmol-2020-316686","article-title":"Managing patients with choroidal melanoma in the COVID-19 era: a personal perspective [editorial]","volume":"104","author":"Damato","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"16","key":"10.1016\/j.mayocpiqo.2021.10.002_bib20","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ejca.2015.07.013","article-title":"United Kingdom Uveal Melanoma Guideline Development Working Group. Uveal melanoma UK national guidelines","volume":"51","author":"Nathan","year":"2015","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.10.002_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijrobp.2012.08.026","article-title":"Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2021.10.002_bib22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0161-6420(93)31446-6","article-title":"Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma: a prospective, randomized, dynamically balanced trial","volume":"100","author":"Char","year":"1993","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.10.002_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study; COMS Report No. 3","volume":"14","year":"1993","journal-title":"Control Clin Trials"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaf9c9","article-title":"Can CT imaging improve targeting accuracy in clip-based proton therapy of ocular melanoma?","volume":"64","author":"Slopsema","year":"2019","journal-title":"Phys Med Biol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.10.002_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9394(77)90133-7","article-title":"Proton irradiation of small choroidal malignant melanomas","volume":"83","author":"Gragoudas","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.10.002_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/096228029600500306","article-title":"Innovative strategies using SUDAAN for analysis of health surveys with complex samples","volume":"5","author":"LaVange","year":"1996","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.10.002_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000455872","article-title":"Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose","volume":"3","author":"Echegaray","year":"2017","journal-title":"Ocul Oncol Pathol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.10.002_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000504312","article-title":"Practice patterns for the treatment of uveal melanoma with iodine-125 plaque brachytherapy: Ocular Oncology Study Consortium Report 5","volume":"6","author":"Binder","year":"2020","journal-title":"Ocul Oncol Pathol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2021.10.002_bib29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","article-title":"Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.10.002_bib30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.118.6.773","article-title":"A\u00a0randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma","volume":"118","author":"Gragoudas","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.10.002_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000094834","article-title":"Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients","volume":"38","author":"Desjardins","year":"2006","journal-title":"Ophthalmic Res"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.10.002_bib32","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/jamaophthalmol.2015.0887","article-title":"Long-term risk of melanoma-related mortality for patients with uveal melanoma treated with proton beam therapy","volume":"133","author":"Lane","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.10.002_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clon.2015.08.007","article-title":"Tumour response in uveal melanomas treated with proton beam therapy","volume":"28","author":"Maschi","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2021.10.002_bib34","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A\u00a0systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.10.002_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12885-020-07083-x","article-title":"Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.10.002_bib36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.eururo.2017.03.028","article-title":"Cost of new technologies in prostate cancer treatment: systematic review of costs and cost effectiveness of robotic-assisted laparoscopic prostatectomy, intensity-modulated radiotherapy, and proton beam therapy","volume":"72","author":"Schroeck","year":"2017","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.10.002_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127814","article-title":"Cost-effectiveness of proton beam therapy for intraocular melanoma","volume":"10","author":"Moriarty","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.10.002_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/IAE.0000000000001757","article-title":"Molecular prognostics for uveal melanoma","volume":"38","author":"Seider","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.mayocpiqo.2021.10.002_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2018.07.045","article-title":"Gene expression profiling and PRAME status versus Tumor-Node-Metastasis staging for prognostication in uveal melanoma","volume":"195","author":"Cai","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.10.002_bib40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/IAE.0000000000002113","article-title":"Relationship of clinical features and baseline tumor size with gene expression profile status in uveal melanoma: a multi-institutional study","volume":"39","author":"Berry","year":"2019","journal-title":"Retina"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:10:27Z","timestamp":1762870227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454821001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2542454821001545"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.10.002","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Uveal Melanoma With Radioactive Iodine 125 Implant Compared With Proton Beam Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}